Brief report: Alternative approaches to the development of effective treatments for autism

Journal of Autism and Developmental Disorders

Volumn 26, Issue 2, 1996, Pages 237-241

  Rimland, Bernard ^b   Baker, Sidney M ^a  

^a Autism Research Institute ^*  (United States)

^b Autism Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MAGNESIUM; PYRIDOXINE;

AUTISM; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG MEGADOSE; FOOD ALLERGY; HUMAN; INFECTION; MALABSORPTION; METABOLIC DISORDER; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; COMPLEMENTARY THERAPIES; HUMANS; INFANT; PATIENT CARE TEAM; TREATMENT OUTCOME;

EID: 0030010418     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02172019     Document Type: Conference Paper

References (7)

1. Gardner, R. W. (1994). Chemical intolerance: Physiological causes and effects and treatment modalities. Ann Arbor, MI: CRC Press.
2. Knivsberg, A. M., Reichelt, K. L., Nodland, M., & Hoien, T. (1995). Autistic syndromes and diet: A followup study. Scandinavian Journal of Educational Research, 39, 223-236.
3. O'Reilly, B. A., & Waring, R. H. (1993). Enzyme and sulphur oxidation deficiencies in autistic children with known food/chemical intolerances. Journal of Orthomolecular Medicine, 4, 198-200.
4. Reap, E. A., & Lawson, J. W. (1990). Stimulation of the immune response by dimethylglycine, a nontoric metabolite. Journal of Laboratory Clinical Medicine, 115, 481-486.
5. Rimland, B. (1995). Studies of high dosage vitamin B6 in autistic children and adults - 1965-1994. San Diego, CA: Autism Research Institute.
6. Shaw, W., Kassen, E., & Chaves, E. (1995). Increasing urinary excretion of analogs of Krebs cycle metabolite and arabinose in two brothers with autistic features. Clinical Chemistry, 41, 1094-1104.
7. Warren, R. P., Yonk, J., Burger, R. W., Odell, D., & Warren, W. L. (1995). DR-positive T cells in autism: Association with decreased plasma levels of the complement C4B protein. Neuropsychobiology, 2, 53-57.